Hirsch Andrew insider trades
Hirsch Andrew has filed 19 Form 4s with the SEC that we hold, for C4 Therapeutics, Inc. (CCCC) (President & CEO, Director) and Editas Medicine, Inc. (EDIT) (Director). Across all of them we count 1 purchase worth $84.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 10,000 shares of C4 Therapeutics, Inc. worth $84.0K, dated 2022-04-12. The first filing on our record is dated 2022-02-23 and the latest 2026-06-22.
C4 Therapeutics, Inc. (CCCC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-12 | P, purchase reported on Form 4 | 10,000 | $84.0K | 2022-04-12 |
Editas Medicine, Inc. (EDIT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1586707) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms